Zwar 1999.
| Methods | Design: patient or provider level RCT | |
| Participants | Country: Australia Setting: primary care or outpatient Specialty: GP/family physicians N health professionals: 157 N patients: ‐ |
|
| Interventions | Description of Groups: AF + educational outreach vs control | |
| Outcomes | Targeted behaviour: rate of antibiotic prescribing for urti Baseline performance: unclear |
|
| Notes | Format: written Source: investigators Frequency: once only Instructions: no explicit target or action plan Nature of change: decrease |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Unable to assess |
| Allocation concealment (selection bias) | Low risk | Cluster trial, allocation after recruitment completed |
| Blinding (performance bias and detection bias) All outcomes | High risk | Self report data |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Unable to assess impact of dropout |
| Selective reporting (reporting bias) | Low risk | Appropriate outcomes reported |
| Baseline similar? | Low risk | Trainees similar at baseline |
| No contamination? | Unclear risk | Unable to assess |
| Risk of bias overall? | High risk | Lack of blinding |
ACE: angiotensin‐converting‐enzyme (inhibitor) AF: audit and feedback AMI: acute myocardial infarction BB: beta blocker CABG: coronary artery bypass graft CHD: coronary heart disease CHF: congestive heart failure CQI: continuous quality improvement CV: cardiovascular DVT: deep vein thrombosis EMR: electronic medical record ER: emergency room FOBT: faecal occult blood test MI: myocardial infarction MRI: magnetic resonance imaging NSAID: non‐steroidal inflammatory drug RCT: randomised controlled trial Rx; treatment QA: quality assurance QI: quality improvement UTI: urinary tract infection vs: versus VTE: venous thromboembolism